Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis

Withdrawn before enrolling

Conditions studied: Kidney Transplantation, Plasmapheresis

In brief

Based on the limited amount of experience with plasmapheresis and CytoGam concomitant use, the researchers seek to evaluate the pharmacokinetics (drug absorption, distribution, and elimination) of this therapy. The researchers are also interested in evaluating the pharmacokinetics of the various immunosuppressant medications that patients will receive such as tacrolimus, mycophenolate mofetil and daclizumab.

Key facts

Study ID

NCT00203281

Run by

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

People needed

0

Starts

2003-02-01

Expected to finish

2009-09-01

Last updated by the study team

2016-10-21

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is a male or female.
• Age of 18-75.
• Patient must have the ability to provide informed consent.
• Positive cross-match with intended donor and/or ABO incompatible with intended donor.

You may not qualify if…

• Patients under the age of 18 or over the age of 75.
• Women that are currently pregnant.
• Patient has a history of any illness that, in the opinion of the investigator(s), might confound the results of the study or pose additional risk to the patient.

Where it is running

• Columbia University — New York, New York, United States
• Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.